Source: Annual Congress 2011 - Treatment of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Siena, E. Pace, M. Ferraro, C. Di Sano, M. Melis, M. Profita, M. Gjomarkaj (Palermo, Italy). Gemcitabine sensitizes lung cancer cells to Fas /Fas ligand system-mediated killing. Eur Respir J 2011; 38: Suppl. 55, 386

Member's Comments

No comment yet.

Related content which might interest you: Involvement of Fas/FasL system in gemcitabine-induced lung cancer cell killing Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Effects of chemotherapeutic drugs and TRAIL (tumor necrosis factor-related apoptosis inducing ligand) on the non-small lung cancer cells Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 The death receptor Fas in CD3+T cells in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004 The role of TNF-related apoptosis inducing ligand (TRAIL) in fibrotic lung disease Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011 Magnolol can induce apoptosis in non-small cell lung cancer via caspase-independent pathway Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Autophagy induces cytoprotection in cisplatin-treated lung cancer cells Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Prx1 modulates the chemosensitivity of lung cancer to docetaxel through suppression of FOXO1-induced apoptosis Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 Role of TNF-related apoptosis inducing ligand (TRAIL) in lung protective immunity against S. pneumoniae Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Prx1 provides resistance to docetaxel-induced apoptosis in lung cancer cells Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Blocking VEGF does not induce proapoptotic effects in the NSCLC cell line A549 Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010 Hypoxic lung cancer-derived exosome decreases anticancer activity of NK cell by targeting CD226 Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 TRAIL and Bax-mediated apoptosis, pathways by which apoptosis may be induced in emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009 Alpha1-antitrypsin inhibits staurosporine-induced apoptosis of NSCLC cells Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Oral presentation: Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008